BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4694958)

  • 1. Haemodynamic effects of low-dose isoproterenol and aminophylline after coronary embolization in dogs.
    Falicov RE; Lipp H; Resnekov L; King S
    Cardiovasc Res; 1973 Jan; 7(1):63-8. PubMed ID: 4694958
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of cardiovascular effects of glucagon by aminophylline.
    Afonso S; Hansing CE; Ansfield TJ; Berndt TB; Rowe GG
    Cardiovasc Res; 1972 May; 6(3):235-9. PubMed ID: 4338472
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of isoproterenol and 1-norepinephrine on function, coronary flow, and oxygen consumption of the intact left ventricle.
    Abe T; Malik AB; O'Kane HO; Geha AS
    Surgery; 1973 Oct; 74(4):562-9. PubMed ID: 4729221
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac effects of isoproterenol during graded myocardial ischemia.
    Lekven J; Kjekshus JK; Mjös OD
    Scand J Clin Lab Invest; 1974 Apr; 33(2):161-71. PubMed ID: 4850884
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic evaluation of glucagon in symptomatic heart disease.
    Armstrong PW; Gold HK; Daggett WM; Austen WG; Sanders CA
    Circulation; 1971 Jul; 44(1):67-73. PubMed ID: 4934830
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of isoproterenol-glucagon infusion in patients with heart disease.
    Polumbo RA; Leighton RF; Weissler AM
    Circulation; 1971 Jun; 43(6):786-91. PubMed ID: 4325386
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamics in the rat with isoproterenol induced cardiac hypertrophy.
    Lin YC
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):213-20. PubMed ID: 4270173
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of molsidomin on left ventricular function and volume in patients with coronary heart disease (author's transl)].
    Karsch KR; Blanke H; Kreuzer H; Rentrop KP
    Z Kardiol; 1979 Feb; 68(2):71-6. PubMed ID: 425616
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
    McKenna DH; Afonso S; Jaramillo CV; Crumpton CW; Rowe GG
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):275-82. PubMed ID: 5968511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative evaluation of the effect of pipolphen and euphyllin on hemodynamics in congenital heart defects with and without pulmonary hypertension].
    Chepkiĭ LP; Shubin MK; Panichkin IuV; Nikishin LF; Brusan LA
    Kardiologiia; 1971 Feb; 11(2):84-8. PubMed ID: 5568396
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical and laboratory evaluation of a "disaster mixture" in cardiovascular resuscitation.
    Wilson RD; Nichols RJ; Poth R
    South Med J; 1967 Aug; 60(8):875-81. PubMed ID: 6036659
    [No Abstract]   [Full Text] [Related]  

  • 12. Intracardiac epinephrine versus isoproterenol in cardiac arrest.
    Warner WA
    Anesth Analg; 1967; 46(2):201-5. PubMed ID: 6066977
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular effects of Cassella 7657 and its interaction with adenosine, NAD and aminophylline in dogs.
    Afonso S; Hansing CE; Rowe GG
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):299-310. PubMed ID: 4360340
    [No Abstract]   [Full Text] [Related]  

  • 14. Action of drugs in patients early after cardiac surgery. I. Comparison of isoproterenol and dopamine.
    Holloway EL; Stinson EB; Derby GC; Harrison DC
    Am J Cardiol; 1975 May; 35(5):656-9. PubMed ID: 1124720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships among cardiac inotropic responses to norepinephrine and cardiac and blood concentrations of H3-norepinephrine during hypothermia.
    Cotten MV; Logan ME; Moore JI
    J Pharmacol Exp Ther; 1967 Feb; 155(2):231-41. PubMed ID: 4381639
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
    Côté P; Polumbo RA; Harrison DC
    Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic effects of experimental hypercitremia.
    Corbascio AN; Smith NT
    Anesthesiology; 1967; 28(3):510-6. PubMed ID: 6023523
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.
    Charlier R; Deltour G; Baudine A; Chaillet F
    Arzneimittelforschung; 1968 Nov; 18(11):1408-17. PubMed ID: 5755904
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of beta-adrenergic receptor blockade on coronary haemodynamics in the resting unanaesthetized dog.
    Pitt B; Green HL; Sugishita Y
    Cardiovasc Res; 1970 Jan; 4(1):89-92. PubMed ID: 4392025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.